CUPR - Cuprina Holdings (Cayman) Ltd Annual Revenue Growth (Last Twelve Months)

Fighting the expansion of healthcare behemoths in the biogel niche, Cuprina Holdings (Cayman) Ltd (CUPR) is expanding its distribution in Asia to diversify a narrow portfolio. The LTM sales volume trend reflects current dynamics, where the parameter value equals 6.40. Cuprina Holdings (Cayman) Ltd (CUPR) leads in complex wound therapy, utilizing patented sterile larvae for the rapid and painless healing of diabetic ulcers without surgery.
Cuprina Holdings (CUPR) - metric breakdowns and financial figures

The indicator is calculated as the percentage change in revenue over the last twelve months relative to the same period last year. This metric measures the speed of business expansion and the degree of stabilization of its market positions. For Cuprina Holdings (Cayman) Ltd (CUPR), the key driver here will be the transition from local clinics to mass supplies of patented bio-dressings. Increased production scalability will directly impact the current level of year-over-year (TTM) sales dynamics. A slowdown in this pace could signal that the company has reached a maturity phase.